Mcqs

Question 1

Front

Answer 1

Back

Question 2

The following monoclonal antibodies for asthma target the interleukins or their receptor; EXCEPT:
- a. Mepolizumab
- b. Omalizumab
- c. Dupilumab
- d. Reslizumab

Answer 2

b. Omalizumab

Question 3

All the following are true regarding ipratropium; EXCEPT:
- a. Short acting bronchodilator
- b. Inhibits the action of acetylcholine
- c. Used for treatment of chronic obstructive pulmonary disease (COPD)
- d. Administered intravenously for acute asthma

Answer 3

d. Administered intravenously for acute asthma

Question 4

The following drugs are used for treatment of rhinitis; EXCEPT:
- a. Budesonide
- b. Ipratropium
- c. Salbutamol
- d. H1 antihistamine

Answer 4

c. Salbutamol

Question 5

The following drugs are matched correctly with pharmacological action; EXCEPT:
- a. N-acetyl cysteine - mucolytic
- b. Dextromethorphan - antitussive
- c. Beclomethasone - anti-inflammatory
- d. Formoterol - decongestant

Answer 5

d. Formoterol - decongestant

Question 6

Mechanism of action of trastuzumab is through binding to:
- a. Estrogen receptors
- b. Both epidermal growth factor and its receptors
- c. Extracellular region of HER-2
- d. Progesterone receptor

Answer 6

c. Extracellular region of HER-2

Question 7

Monoclonal antibodies for asthma treatment interact directly with the following inflammatory mediators; EXCEPT:
- a. Interleukin-5
- b. Histamine
- c. IgE
- d. TSLP

Answer 7

b. Histamine

Question 8

All the following are TRUE regarding the inhaled corticosteroid (ICS); EXCEPT:
- a. Used for chronic obstructive airway disease
- b. Low dose ICS associated with high risk of systemic side effects
- c. They decrease the asthma symptoms frequency
- d. 50-90% of inhaled dose is swallowed

Answer 8

b. Low dose ICS associated with high risk of systemic side effects

Question 9

The following are cough suppressant drugs; EXCEPT:
- a. Dextromethorphan
- b. Carbocystine
- c. Noscapine
- d. Diphenhydramine

Answer 9

b. Carbocystine

Question 10

Intranasal ipratropium relieves which of the rhinitis symptoms:
- a. Nasal congestion
- b. Itching
- c. Sneezing
- d. Runny nose

Answer 10

d. Runny nose

Question 11

The therapeutic effect of salmeterol in asthma is mediated through:
- a. Blocking the muscarinic receptor of airway smooth muscles
- b. Activation of beta 2 receptor of airway smooth muscle
- c. Inhibition of inflammatory mediator synthesis in inflammatory cells
- d. Blocking the adenosine receptor of airway smooth muscles

Answer 11

b. Activation of beta 2 receptor of airway smooth muscle

Question 12

The following statements are TRUE regarding omalizumab; EXCEPT:
- a. It has anti-inflammatory effects
- b. It is used to treat uncontrolled severe allergic asthma
- c. It is taken by subcutaneous injection
- d. It blocks IgE receptors

Answer 12

d. It blocks IgE receptors

Question 13

Which of the following drugs is used to treat dry cough?
- a. Bromhexine
- b. Dextromethorphan
- c. Guaifenesin
- d. N-acetylcysteine

Answer 13

b. Dextromethorphan

Question 14

What are the three subgroups of rhinitis?

Answer 14

Allergic, infectious, non-allergic

Question 15

What symptom is caused by vasodilation in rhinitis?

Answer 15

Nasal congestion/obstruction

Question 16

Name two types of non-allergic rhinitis.

Answer 16

Drug-induced, hormone-induced